Area of research
Immunology · Genetics
Research interest
Research interests include Immune Cell Function and Interaction, Hemoglobinopathies and Related Disorders, Cancer Immunotherapy and Biomarkers, and Neuroblastoma Research and Treatments.
Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers
Clinical Validation of a Volumetric Absorptive Micro-Sampling Device for Pharmacokinetic Studies With Tranexamic Acid
Tranexamic acid through intravenous, intramuscular and oral routes: an individual participant data meta‐analysis of pharmacokinetic studies in healthy volunteers
PF441 RED BLOOD CELLS PROPERTIES IN PATIENTS WITH SICKLE CELL DISEASE TREATED WITH LENTIGLOBIN GENE THERAPY IN THE HGB‐205 TRIAL
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome
Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report
Gene Therapy in a Patient with Sickle Cell Disease
Metabolic effects of fasting on human and mouse blood in vivo
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome
Relapses in hepatoblastoma patients: Clinical characteristics and outcome – Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)